FIGURE 2.
Protective level, booster dose response, and overall protective efficacy proportions for 22‐, 30‐, and 35‐year follow‐ups after a primary three‐dose series of HBV vaccine, Alaska.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.